{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12452287",
  "DateCompleted": {
    "Year": "2003",
    "Month": "02",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0899-823X",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "11",
        "PubDate": {
          "Year": "2002",
          "Month": "Nov"
        }
      },
      "Title": "Infection control and hospital epidemiology",
      "ISOAbbreviation": "Infect Control Hosp Epidemiol"
    },
    "ArticleTitle": "Ciprofloxacin and Clostridium difficile--associated diarrhea.",
    "Pagination": {
      "StartPage": "637",
      "EndPage": "638",
      "MedlinePgn": "637-8; author reply 638"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Thomas",
        "ForeName": "Claudia",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Golledge",
        "ForeName": "Clayton L",
        "Initials": "CL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Riley",
        "ForeName": "Thomas V",
        "Initials": "TV"
      }
    ],
    "PublicationTypeList": [
      "Letter",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Infect Control Hosp Epidemiol",
    "NlmUniqueID": "8804099",
    "ISSNLinking": "0899-823X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Infect Control Hosp Epidemiol. 2001 Sep;22(9):572-5",
      "PMID": "11732787"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Australia"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Clostridioides difficile"
    },
    {
      "QualifierName": [
        "etiology",
        "microbiology"
      ],
      "DescriptorName": "Clostridium Infections"
    },
    {
      "QualifierName": [
        "microbiology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [
        "chemically induced",
        "microbiology"
      ],
      "DescriptorName": "Diarrhea"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}